Greehey CCRI News & Events Archive

Filter results


 

Scientia: Dr Peter Houghton – Novel Therapeutics For Childhood Solid Tumours

February 15, 2017

Dr Peter Houghton’s group implements preclinical trials to identify new drugs that may be effective and less toxic treatments against childhood cancers. From patient-derived xenografts in immunodeficient mice to utilising canine cancer patients as mode …


Washington Post: A new urgency to protect survivors of childhood cancer

December 25, 2016

SAN ANTONIO — When Brittany Galan was diagnosed with leukemia at 6 weeks old, doctors warned her parents she had little chance of surviving — she was so young and so sick. But after being treated with chemotherapy, “I lived and lived!” said the exubera …


Ft. Worth Business: Cancer treatments that save children’s lives exact a heavy price years later

December 16, 2016

The lifesaving chemo, however, took a heavy toll. It “messed me up neurologically,” Galan said. In grade school, she had trouble with reading and math and eventually went on ADHD medication. In college, the once-avid runner developed a heart problem. R …


Bexar County Medical Society: San Antonio Medicine October 2016

October 1, 2016


Europe PMC: Alkylating Agent-Induced NRF2 Blocks Endoplasmic Reticulum Stress-Mediated Apoptosis via Control of Glutathione Pools and Protein Thiol Homeostasis.

September 15, 2016

Zanotto-Filho A1, Masamsetti VP1, Loranc E1, Tonapi SS1, Gorthi A1, Bernard X1, Gonçalves RM2, Moreira JC2, Chen Y1, Bishop AJ1 Abstract  Alkylating agents are a commonly used cytotoxic class of anticancer drugs. Understanding the mechanisms whereby ce …


Hyundai Hope on Wheels Awards $250,000 Research Grant to Ut Health Science Center San Antonio in Honor of National Childhood Cancer Awareness Month

September 12, 2016

San Antonio, TX – September 12 – Hyundai Hope On Wheels® (HHOW) and San Antonio-area Hyundai dealers will present UT Health Science Center San Antonio with a $250,000 Scholar Grant to be used to improve care and increase treatment options for kids with …


The American Journal of Pathology: Musashi1 Impacts Radio-Resistance in Glioblastoma by Controlling DNA-Protein Kinase Catalytic Subunit

September 1, 2016

The conserved RNA-binding protein Musashi1 (MSI1) has been characterized as a stem cell marker, controlling the balance between self-renewal and differentiation and as a key oncogenic factor in numerous solid tumors, including glioblastoma. To explore …


UT Health SA Newsroom: Health Science Center, UTSA gain $4.6 million for cancer research

August 25, 2016

The Center for Innovative Drug Discovery (CIDD), a joint program of the UT Health Science Center San Antonio and The University of Texas at San Antonio (UTSA), is receiving a $4,598,728 grant from the Cancer Prevention & Research Institute of Texas …


San Antonio Report: Commentary: Are Questions More Powerful Than Answers?

July 23, 2016

In the afternoon, the students had an opportunity to meet with Dr. Alexander Pertsemlidis, associate professor of pediatrics, hematology, and oncology at the Greehey Children’s Cancer Research Institute at the University of Texas Health Science Center. …


San Antonio Business Journal: SA biotech company and Health Science Center to use the power of collaboration to combat cancer

July 13, 2016

One of San Antonio’s more promising bioscience companies, bioAffinity Technologies Inc., has locked up a key deal, renewing its collaborative agreement with the University of Texas Health Science Center at San Antonio. The extension will allow the two …